[Türkçe]

Turkish Society of Cardiology Young Cardiologists Bulletin Year: 5 Number: 6 / 2022


Turkish Society of Cardiology
Young Cardiologists
President
Dr. Muzaffer Değertekin

Coordinator for the
Board of Directors

Dr. Ertuğrul Okuyan

Coordinator for the
Board of Directors

Dr. Can Yücel Karabay

Members
Dr. Adem Aktan
Dr. Gülşah Aktüre
Dr. Bayram Arslan
Dr. İnanç Artaç
Dr. Ahmet Oğuz Aslan
Dr. Görkem Ayhan
Dr. Ahmet Anıl Başkurt
Dr. Özkan Bekler
Dr. Oğuzhan Birdal
Dr. Yusuf Bozkurt Şahin
Dr. Serkan Bulgurluoğlu
Dr. Ümit Bulut
Dr. Veysi Can
Dr. Mustafa Candemir
Dr. Murat Çap
Dr. Göksel Çinier
Dr. Ali Çoner
Dr. Yusuf Demir
Dr. Ömer Furkan Demir
Dr. Murat Demirci
Dr. Ayşe İrem Demirtola Mammadli
Dr. Süleyman Çağan Efe
Dr. Mehmet Akif Erdöl
Dr. Kubilay Erselcan
Dr. Kerim Esenboğa
Dr. Duygu Genç
Dr. Kemal Göçer
Dr. Elif Güçlü
Dr. Arda Güler
Dr. Duygu İnan
Dr. Hasan Burak İşleyen
Dr. Muzaffer Kahyaoğlu
Dr. Sedat Kalkan
Dr. Yücel Kanal
Dr. Özkan Karaca
Dr. Ahmet Karaduman
Dr. Mustafa Karanfil
Dr. Ayhan Kol
Dr. Fatma Köksal
Dr. Mevlüt Serdar Kuyumcu
Dr. Yunus Emre Özbebek
Dr. Ahmet Özderya
Dr. Yasin Özen
Dr. Ayşenur Özkaya İbiş
Dr. Çağlar Özmen
Dr. Selvi Öztaş
Dr. Hasan Sarı
Dr. Serkan Sivri
Dr. Ali Uğur Soysal
Dr. Hüseyin Tezcan
Dr. Nazlı Turan
Dr. Berat Uğuz
Dr. Örsan Deniz Urgun
Dr. İdris Yakut
Dr. Mustafa Yenerçağ
Dr. Mehmet Fatih Yılmaz
Dr. Yakup Yiğit
Dr. Mehmet Murat Yiğitbaşı

Bulletin Editors
Dr. Muzaffer Değertekin
Dr. Bülent Mutlu
Dr. Süleyman Çağan Efe
Dr. Göksel Çinier
Dr. Duygu İnan
Dr. Sedat Kalkan

Contributors
Dr. Onur Akhan
Dr. Fatih Aksoy
Dr. Derya Baykiz
Dr.  İlyas Çetin
Dr. Uğur Ozan Demirhan
Dr. Elif Ayduk Gövdeli
Dr. Mustafa Ferhat Keten
Dr. Bengisu Keskin Meriç
Dr. İbrahim Halil Özdemir
Dr. Mehmet Arslan
Dr. Hüseyin Durak
Dr. Levent Pay


 


Turkish Society of Cardiology Young Cardiologists Bulletin / "TSCYOUNG" Eylül 2022 (6)
Turkish Society of Cardiology Young Bulletin 5:6

Dear Colleagues,

As the Young Cardiologists Group of the Turkish Society of Cardiology, we are pleased to present the sixth issue of the TSC Bulletin for 2022, which includes the latest clinical trials in the field of cardiology. The studies in the bulletin were selected from the Hot Line studies published at the ESC 2022 Congress. The studies have been summarized as briefly as possible to provide an overview, provide both informative and useful references for daily practice.
Thanks to our colleagues who contributed to bulletin. We hope it will be a useful resource for our colleagues.

Issue Summary
Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention(AXIOM-SSP)
Dr. Mustafa Ferhat Keten

Acetazolamide in Acute Decompensated Heart Failure with Volume Overload (ADVOR)
Dr. Uğur Ozan Demirhan

Revascularisation for ischemic ventricular dysfunction: REVIVED trial
Dr. Elif Ayduk Gövdeli

Evening dosing of blood pressure medication not better than morning dosing: TIME trial
Dr. İbrahim Halil Özdemir

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
Dr. Fatih Aksoy

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
Dr. İbrahim Halil Özdemir

More precise algorithms are needed to select patients for invasive coronary testing (Dan-NICAD 2 trial)
Dr. Onur Akhan

Safety and Efficacy Study of artificial intelligence (AI) LVEF (EchoNet-RCT)
Dr. Bengisu Keskin Meriç

Angiotensin receptor blockers (ARB) and ß-blockers in Marfan syndrome: a meta-analysis of individual patient data from randomized trials
Dr. İlyas Çetin

Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease
Dr. Bengisu Keskin Meriç

Artificial intelligence identifies severe aortic stenosis from routine echocardiograms (AI-ENHANCED AS study)
Dr. Onur Akhan

Finerenone and Effects on Mortality in Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Analysis
Dr. Mehmet Arslan

Blood pressure and oxygenation targets in post-resuscitation care, a randomized clinical trial: the BOX trial
Dr. Elif Ayduk Gövdeli

Anticoagulation and Antiplatelet Therapy for the Prevention of Venous and Arterial Thrombotic Events in Critically Sick Patients with COVID-19: COVID-PACT
Dr. İlyas Çetin

Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial
Dr. Uğur Ozan Demirhan

Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eBRAVE-AF) trial
Dr. Mustafa Ferhat Keten

FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease (FRAME-AMI)
Dr. Derya Baykiz

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Dr. Levent Pay

Rivaroxaban in Rheumatic Heart Disease – Associated Atrial Fibrillation
Dr. Levent Pay

PACIFIC-AMI (A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction)
Dr. Hüseyin Durak

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease (FOURIER OLE)
Dr. Mehmet Arslan

Prediction of Recurrent Events with 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients with Myocardial Infarction (PRE18 FFIR)
Dr. Derya Baykiz

 2025 © Turkish Society of Cardiology.